Ironwood Pharmaceuticals | IRWD - Current Liabilities


Ironwood Pharmaceuticals reported $242.5M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 356.58M 26.56M Sep/2025
Agios Pharmaceuticals USD 82.21M 7.45M Dec/2025
Akebia Therapeutics USD 133.38M 14.66M Sep/2025
Almirall EUR 298.52M 54.91M Jun/2025
Alnylam Pharmaceuticals USD 1.47B 89.13M Dec/2025
Amarin USD 182.23M 3.71M Sep/2025
Ardelyx USD 83.39M 1.67M Sep/2025
Astellas Pharma JPY 1.32T 873M Dec/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Charles River Laboratories USD 1.12B 1.57M Dec/2025
Coherus Biosciences USD 372.3M 108.67M Sep/2025
Emergent BioSolutions USD 651.3M 12.7M Dec/2023
Esperion Therapeutics USD 359.03M 60.24M Sep/2025
Exact Sciences USD 641.15M 56.89M Dec/2025
Halozyme Therapeutics USD 177.09M 660.14M Dec/2025
Incyte USD 1.52B 176.44M Dec/2025
Ironwood Pharmaceuticals USD 242.5M 9.98M Sep/2025
Karyopharm Therapeutics USD 87.16M 12.06M Sep/2025
Lexicon Pharmaceuticals USD 34.84M 75.86M Jun/2025
MacroGenics USD 44.47M 5.47M Sep/2025
Moderna USD 1.99B 306M Dec/2025
Myriad Genetics USD 148M 51.9M Sep/2025
Pacira USD 107.08M 206.09M Sep/2025
PTC Therapeutics USD 968.43M 102.18M Dec/2025
Puma Biotechnology USD 82.73M 3.63M Sep/2025
Sarepta Therapeutics USD 921.42M 1.48M Sep/2025
Takeda JPY 2.61T 470.53B Dec/2025
Ultragenyx Pharmaceutical USD 340.02M 46.78M Sep/2025
Vanda Pharmaceuticals USD 145.16M 27.29M Dec/2025